Sunshine Pharma and Yaosheng Pharmaceutical have signed a research and development agreement for the innovative antibacterial drug IMB0304.

On April 10, 2026, Sun Pharma and the Institute of Medical Biotechnology at the Chinese Academy of Medical Sciences officially signed a research and development cooperation agreement for innovative antibacterial drug IMB0304.